comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 18:18:15 - browse：34

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Delta passengers in Vegas fall sick while waiting on flight in triple

WSS

How a Boston hospital is priming medical residents to use GPT

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Judge denies Trump's request for new trial in E. Jean Carroll case

The stock market has soared this year, but will it last? Experts weigh in

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

leisure time

comprehensive

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

A new ‘biological computer' targets cancer while sparing healthy cells

Tori Bowie and the unacceptable rates of Black maternal death

STAT Boddities: What happens to the brain when we get scared?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Dementia risk linked to living in disadvantaged areas: Study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stanford president’s abrupt resignation sparks debate

23andMe had bad news about my health. I wish a person had delivered it

Hormonal contraceptives don’t actually treat endometriosis

focus

When a patient nears the end, a feared therapy can comfort

Juul documents reveal insider tactics on political lobbying

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Congress might make insulin pumps more accessible to the blind

Scientists grapple with ethics of stem cell research

AMAs digital advisors table RPM coding reform proposal, again

focus

knowledge

hotspot

Wikipedia